Rajiv De Silva
2011 - Valeant Pharmaceuticals International
In 2011, Rajiv De Silva earned a total compensation of $3.1M as President and Chief Operating Officer, Specialty Pharmaceuticals at Valeant Pharmaceuticals International, a 4% increase compared to previous year.
Compensation breakdown
| Bonus | $500,000 |
|---|---|
| Non-Equity Incentive Plan | $756,563 |
| Salary | $750,000 |
| Stock Awards | $1,068,351 |
| Other | $32,552 |
| Total | $3,107,466 |
De Silva received $1.1M in stock awards, accounting for 34% of the total pay in 2011.
De Silva also received $500K in bonus, $756.6K in non-equity incentive plan, $750K in salary and $32.6K in other compensation.
Rankings
In 2011, Rajiv De Silva's compensation ranked 2,057th out of 10,747 executives tracked by ExecPay. In other words, De Silva earned more than 80.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,057 out of 10,747 | 81st |
Division Manufacturing | 742 out of 3,960 | 81st |
Major group Chemicals And Allied Products | 160 out of 1,033 | 85th |
Industry group Drugs | 93 out of 781 | 88th |
Industry Pharmaceutical Preparations | 79 out of 571 | 86th |
Source: SEC filing on April 30, 2012.
De Silva's colleagues
We found six more compensation records of executives who worked with Rajiv De Silva at Valeant Pharmaceuticals International in 2011.
2011
J Pearson
Valeant Pharmaceuticals International
Chief Executive Officer
2011
Howard Schiller
Valeant Pharmaceuticals International
Chief Financial Officer
2011
Brian Stolz
Valeant Pharmaceuticals International
Executive Vice President of Administration and Chief Human Capital Officer
2011
Mark Durham
Valeant Pharmaceuticals International
Senior Vice President, Human Resources
2011
Robert Chai-Onn
Valeant Pharmaceuticals International
Chief Legal Officer
2011
Philip Loberg
Valeant Pharmaceuticals International